EUVIMEDEUVIMED entdecken
Crossref

Ginsenoside Rg1 modulates PI3K/AKT pathway for enhanced osteogenesis via GPER

Zhongjing Jiang, Linhua Deng, Mengjun Li, Emmanuel Alonge, Yanling Wang, Yunjia Wang

Phytomedicine · 2024

DOI: 10.1016/j.phymed.2023.155284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2024. Verfasst von Zhongjing Jiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; National Clinical Research C…. Hauptthemen laut MEDLINE: Osteogenesis, Osteoporosis, Anthraquinones, Ginsenosides. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Natural Science Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Osteoporosis is a systemic skeletal disorder characterized by decreased bone density and the degradation of bone tissue microarchitecture. Ginsenoside Rg1, derived from Panax ginseng, has been a part of traditional Chinese medicine in China for centuries, particularly for treating osteoporosis. However, there remains limited research on the osteogenic potential of Rg1 within the glucocorticoid-induced osteoporosis (GIOP) model and its specific mechanisms. PURPOSE: The primary objective of this study is to investigate the osteogenic potential of Rg1 within the GIOP model and explore the signaling pathways associated with its in vivo and in vitro effects. METHODS: Cell proliferation, differentiation and mineralization were evaluated by the Cell counting kit 8(CCK8) assay, alkaline phosphatase (ALP) test and Alizarin Red S staining, respectively. The qPCR technique was used to determine the relative expression of mRNA and the western blot was used to determine the relative expression of protein. In vivo experiments, spinal vertebrae staining in zebrafish larvae was accomplished by alizarin red S staining. RESULTS: Zebrafish larvae's hatching, survival, malformation, and heart rate were unaffected by 50 μM of Rg1 in vivo, while the MEC3T3-E1 cell line's proliferation was unaffected by 50 μM of Rg1 in vitro. Meanwhile, Rg1 was shown to improve osteogenic differentiation or bone formation as well as the level of mRNA expression of osteogenic markers in vivo and in vitro. Treatment with Rg1 significantly increased the expression of G protein-coupled estrogen receptor (GPER) and pAKT. In addition, the GPER inhibitor G15 could significantly reduce the mRNA and protein expression levels of GPER and phosphorylated AKT, LY294002, a PI3K/AKT pathway inhibitor, markedly suppresses the expression of phosphorylated AKT, yet shows no significant impact on GPER expression. Both G15 and LY294002 can significantly blocked the Rg1-mediated enhancement of osteogenesis capacity in the GIOP model. In contrast, when both the agonists G1 of GPER and LY294002 were added, G1 increased the relative expression of mRNA and protein of GPER, but not the expression of osteogenic capacity and osteogenic markers. CONCLUSIONS: This study investigates the mineralization effects and mechanisms of Ginsenoside Rg1 both in vitro and in vivo. For the first time, we propose that Rg1 might regulate osteogenesis by modulating AKT phosphorylation through mediating GPER expression within the PI3K/AKT pathway in the GIOP model. This discovery introduces novel targets and avenues for osteoporosis treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteogenesisOsteoporosisAnthraquinonesGinsenosidesAnimalsProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesZebrafishReceptors, G-Protein-CoupledCell DifferentiationEstrogensGlucocorticoidsRNA, Messenger

Stichwörter der Autor:innen

Differentiation and mineralizationGPERGinsenoside Rg1MC3T3-E1 cellsPI3K/AKT signaling pathwayZebrafish

Substanzen

alizarinProto-Oncogene Proteins c-aktginsenoside Rg1Phosphatidylinositol 3-KinasesReceptors, G-Protein-CoupledEstrogensGlucocorticoidsRNA, MessengerAnthraquinonesGinsenosides

Autor:innen und Institutionen

  • Department of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South Univers…
  • Hunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control, Changsha Hospital for Maternal & Child Health Care Affiliated to Hunan Normal University, Changsha, China.

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Natural Science Foundation of Hunan Province
  • Science and Technology Program of Hunan Province

Zitieren

APA

Jiang, Z., Deng, L., Li, M., Alonge, E., Wang, Y., & Wang, Y. (2024). Ginsenoside Rg1 modulates PI3K/AKT pathway for enhanced osteogenesis via GPER. Phytomedicine. https://doi.org/10.1016/j.phymed.2023.155284

Vancouver

Jiang Z, Deng L, Li M, Alonge E, Wang Y, Wang Y. Ginsenoside Rg1 modulates PI3K/AKT pathway for enhanced osteogenesis via GPER. Phytomedicine. 2024. doi:10.1016/j.phymed.2023.155284

BibTeX
@article{Jiang2024,
  author = {Jiang, Zhongjing and Deng, Linhua and Li, Mengjun and Alonge, Emmanuel and Wang, Yanling and Wang, Yunjia},
  title = {Ginsenoside Rg1 modulates PI3K/AKT pathway for enhanced osteogenesis via GPER},
  journal = {Phytomedicine},
  year = {2024},
  doi = {10.1016/j.phymed.2023.155284}
}
Kostenlos starten →